Published in Exp Cell Res on June 15, 1998
Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Invest (2002) 3.90
Phenobarbital regulates nuclear expression of HNF-4alpha in mouse and rat hepatocytes independent of CAR and PXR. Hepatology (2006) 0.90
Keratinocyte serum-free medium maintains long-term liver gene expression and function in cultured rat hepatocytes by preventing the loss of liver-enriched transcription factors. Int J Biochem Cell Biol (2006) 0.89
Recombinant human epidermal growth factor treatment of radiation-induced severe oral mucositis in patients with head and neck malignancies. Eur J Cancer Care (Engl) (2009) 0.88
Loss of hepatocyte ERBB3 but not EGFR impairs hepatocarcinogenesis. Am J Physiol Gastrointest Liver Physiol (2015) 0.76
Bone marrow as a potential source of hepatic oval cells. Science (1999) 8.52
Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand. Nat Med (2000) 4.40
Structure and function of the interferon-beta enhanceosome. Cold Spring Harb Symp Quant Biol (1998) 3.81
Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET. Oncogene (1991) 3.41
Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor. EMBO J (1991) 3.20
Population expansion, clonal growth, and specific differentiation patterns in primary cultures of hepatocytes induced by HGF/SF, EGF and TGF alpha in a chemically defined (HGM) medium. J Cell Biol (1996) 3.13
The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J Cell Biol (1995) 2.67
Lysosomal protease pathways to apoptosis. Cleavage of bid, not pro-caspases, is the most likely route. J Biol Chem (2000) 2.62
Cross-talk between epidermal growth factor receptor and c-Met signal pathways in transformed cells. J Biol Chem (2000) 2.46
Negative protein 1, which is required for function of the chicken lysozyme gene silencer in conjunction with hormone receptors, is identical to the multivalent zinc finger repressor CTCF. Mol Cell Biol (1997) 2.37
Second neoplasms after acute lymphoblastic leukemia in childhood. N Engl J Med (1991) 2.27
Hepatic oval cells express the hematopoietic stem cell marker Thy-1 in the rat. Hepatology (1998) 2.21
Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA. Am J Pathol (1993) 2.14
Features of myocardial injury in severe organophosphate poisoning. Clin Toxicol (Phila) (2014) 2.09
PRDI-BF1/Blimp-1 repression is mediated by corepressors of the Groucho family of proteins. Genes Dev (1999) 2.09
Prognostic factors and recurrence pattern in node-negative advanced gastric cancer. Eur J Surg Oncol (2012) 2.05
Hepatocyte growth factor/scatter factor is a motogen for interneurons migrating from the ventral to dorsal telencephalon. Neuron (2001) 2.03
Successful bone-marrow transplantation for infantile malignant osteopetrosis. N Engl J Med (1980) 1.95
Hepatocyte growth factor (hepatopoietin A) rapidly increases in plasma before DNA synthesis and liver regeneration stimulated by partial hepatectomy and carbon tetrachloride administration. Hepatology (1991) 1.88
Extracellular matrix remodeling at the early stages of liver regeneration in the rat. Hepatology (1997) 1.79
Morphogenetic events in mixed cultures of rat hepatocytes and nonparenchymal cells maintained in biological matrices in the presence of hepatocyte growth factor and epidermal growth factor. Hepatology (1999) 1.72
Changes in WNT/beta-catenin pathway during regulated growth in rat liver regeneration. Hepatology (2001) 1.71
Long-term preservation and storage of mycobacteria. Appl Microbiol (1972) 1.69
Type 2 diabetes-associated genetic variants discovered in the recent genome-wide association studies are related to gestational diabetes mellitus in the Korean population. Diabetologia (2008) 1.67
Emergent excitations in a geometrically frustrated magnet. Nature (2002) 1.66
Stenting from the vertebral artery to the posterior inferior cerebellar artery. AJNR Am J Neuroradiol (2011) 1.64
Hepatic oval cell activation in response to injury following chemically induced periportal or pericentral damage in rats. Hepatology (1998) 1.55
Preservation of mycobacteria: 100 percent viability of suspensions stored at -70 C. Appl Microbiol (1973) 1.54
Efficient recruitment of TFIIB and CBP-RNA polymerase II holoenzyme by an interferon-beta enhanceosome in vitro. Proc Natl Acad Sci U S A (1998) 1.54
Angiotensin-converting enzyme gene polymorphism and vascular manifestations in Korean patients with SLE. Lupus (2002) 1.53
Two new acute lymphoblastic leukemia cell lines with early B-cell phenotypes. Blood (1982) 1.52
Expression and activation of pro-MMP-2 and pro-MMP-9 during rat liver regeneration. Hepatology (2000) 1.50
Cross-cultural adaptation and validation of Korean Western Ontario and McMaster Universities (WOMAC) and Lequesne osteoarthritis indices for clinical research. Osteoarthritis Cartilage (2001) 1.49
Growth factor signal transduction immediately after two-thirds partial hepatectomy in the rat. Cancer Res (1999) 1.48
Coexistence of ankylosing spondylitis and mixed connective tissue disease in a single patient. Clin Exp Rheumatol (1999) 1.46
Chemotherapy for induction of remission of childhood acute myeloid leukemia followed by marrow transplantation or multiagent chemotherapy: a report from the Childrens Cancer Group. J Clin Oncol (1994) 1.45
Induction of DNA synthesis in cultured rat hepatocytes through stimulation of alpha 1 adrenoreceptor by norepinephrine. Science (1985) 1.43
T-category reflects the histopathologic characteristics of gallbladder cancer. Eur J Surg Oncol (2012) 1.41
Hepatocyte growth factor. Hepatology (1992) 1.41
Quality of marital life in Korean patients with spondyloarthropathy. Clin Rheumatol (2003) 1.40
Autologous bone marrow transplantation in non-Hodgkin's lymphoma: monoclonal antibodies plus complement for ex vivo marrow treatment. Am J Med (1988) 1.39
[Somatic gene therapy. Initial clinical applications and current research approach]. Fortschr Med (1995) 1.39
Downregulation of Spry2 by miR-21 triggers malignancy in human gliomas. Oncogene (2011) 1.39
Sustained expression of naked plasmid DNA encoding hepatocyte growth factor in mice promotes liver and overall body growth. Hepatology (2001) 1.36
Collagenase pretreatment and the mitogenic effects of hepatocyte growth factor and transforming growth factor-alpha in adult rat liver. Hepatology (1994) 1.36
Subgenus classification of Acanthamoeba by riboprinting. Korean J Parasitol (1998) 1.35
Expression of hepatocyte growth factor mRNA in regenerating rat liver after partial hepatectomy. Biochem Biophys Res Commun (1991) 1.33
Structural and functional characterization of the mouse hepatocyte growth factor gene promoter. J Biol Chem (1994) 1.31
Histological organization in hepatocyte organoid cultures. Am J Pathol (2001) 1.31
Optical coherence tomography evaluation of zotarolimus-eluting stents at 9-month follow-up: comparison with sirolimus-eluting stents. Heart (2009) 1.31
Screening for candidate hepatic growth factors by selective portal infusion after canine Eck's fistula. Hepatology (1991) 1.30
Nitric oxide prevents tumor necrosis factor alpha-induced rat hepatocyte apoptosis by the interruption of mitochondrial apoptotic signaling through S-nitrosylation of caspase-8. Hepatology (2000) 1.29
A role for mitochondrial Bak in apoptotic response to anticancer drugs. J Biol Chem (2001) 1.28
Immediate early detection of urokinase receptor after partial hepatectomy and its implications for initiation of liver regeneration. Hepatology (1995) 1.28
The processing and utilization of hepatocyte growth factor/scatter factor following partial hepatectomy in the rat. Hepatology (2001) 1.27
Minimally invasive localization of oncolytic herpes simplex viral therapy of metastatic pleural cancer. Cancer Gene Ther (2006) 1.23
Aerosol-delivered programmed cell death 4 enhanced apoptosis, controlled cell cycle and suppressed AP-1 activity in the lungs of AP-1 luciferase reporter mice. Gene Ther (2007) 1.22
Nitric oxide suppression of apoptosis occurs in association with an inhibition of Bcl-2 cleavage and cytochrome c release. J Biol Chem (1998) 1.20
Bile ductular damage induced by methylene dianiline inhibits oval cell activation. Am J Pathol (1997) 1.20
Intestinal bacterial metabolism of flavonoids and its relation to some biological activities. Arch Pharm Res (1998) 1.20
Arabidopsis eIF3e (INT-6) associates with both eIF3c and the COP9 signalosome subunit CSN7. J Biol Chem (2001) 1.19
Spinal cord compression in malignant lymphoma. Treatment and results. Cancer (1976) 1.19
The incidence of second neoplasms following megavoltage radiation for pediatric tumors. Cancer (1985) 1.19
Cationic colloidal silica membrane perturbation as a means of examining changes at the sinusoidal surface during liver regeneration. Am J Pathol (1999) 1.19
Hepatic cavernous hemangioma: sonographic patterns and speed of contrast enhancement on multiphase dynamic MR imaging. AJR Am J Roentgenol (1998) 1.18
A randomized study of the prevention of acute graft-versus-host disease. N Engl J Med (1982) 1.18
Formation of phalanges and small joints by tissue-engineering. J Bone Joint Surg Am (1999) 1.15
The presence of hepatocyte growth factor in the developing rat. Development (1992) 1.15
Localization of hepatocyte growth factor in human and rat tissues: an immunohistochemical study. Hepatology (1991) 1.13
Hepatopoietin A: partial characterization and trypsin activation of a hepatocyte growth factor. Cancer Res (1985) 1.10
Hepatocyte growth factor in human placenta and trophoblastic disease. Am J Pathol (1991) 1.09
Phylogenetic relationships among Acanthamoeba spp. based on PCR-RFLP analyses of mitochondrial small subunit rRNA gene. Korean J Parasitol (1999) 1.09
Hepatocyte regeneration in acute fulminant and nonfulminant hepatitis: a study of proliferating cell nuclear antigen expression. Hepatology (1992) 1.08
Improved treatment satisfaction and weight-related quality of life with exenatide once weekly or twice daily. Diabet Med (2009) 1.08
Purification and characterization of a secretory serine proteinase of Acanthamoeba healyi isolated from GAE. J Parasitol (2000) 1.07
Effect of 2% dimethyl sulfoxide on the mitogenic properties of epidermal growth factor and hepatocyte growth factor in primary hepatocyte culture. J Cell Physiol (1991) 1.07
Presence of urokinase in serum-free primary rat hepatocyte cultures and its role in activating hepatocyte growth factor. Cancer Res (1996) 1.05
Altered responses of regenerating hepatocytes to norepinephrine and transforming growth factor type beta. J Cell Physiol (1989) 1.05
Sonography of inflammatory bowel disease: findings and value in differential diagnosis. AJR Am J Roentgenol (1994) 1.03
Lymph node ratio is an independent prognostic factor in patients with rectal cancer treated with preoperative chemoradiotherapy and curative resection. Eur J Surg Oncol (2012) 1.02
The five amino acid-deleted isoform of hepatocyte growth factor promotes carcinogenesis in transgenic mice. Oncogene (1999) 1.02
Nonlinear dynamics of domain-wall propagation in epitaxial ferroelectric thin films. Phys Rev Lett (2009) 1.02
Serum-free, long-term cultures of human hepatocytes: maintenance of cell morphology, transcription factors, and liver-specific functions. Biochem Biophys Res Commun (2000) 1.02
Cardiac tamponade as an initial manifestation of systemic lupus erythematosus--single case report. J Korean Med Sci (1997) 1.01
Thyroid dysfunction among long-term survivors of bone marrow transplantation. Am J Med (1982) 1.01
Effects of radiation on testicular function in long-term survivors of childhood acute lymphoblastic leukemia: a report from the Children Cancer Study Group. J Clin Oncol (1990) 1.01
Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer. Br J Cancer (2013) 0.98
Expression of elongation factor-1 gamma-related sequence in human pancreatic cancer. Pancreas (1992) 0.98
Galactosylated chitosan-graft-poly(ethylene glycol) as hepatocyte-targeting DNA carrier. J Control Release (2001) 0.98
Polymorphisms in the Matrilin-1 gene and risk of mandibular prognathism in Koreans. J Dent Res (2010) 0.98
Excessive Wnt/β-catenin signaling disturbs tooth-root formation. J Periodontal Res (2012) 0.97